American Society for Microbiology, Microbiology Spectrum, 3(9), 2021
DOI: 10.1128/spectrum.01131-21
Full text: Download
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays with excellent clinical performance are essential for reliable estimation of the persistence of immunity after infection or vaccination. In this paper we present a thoroughly validated SARS-CoV-2 serological assay with excellent clinical performance and good comparability to neutralizing antibody titers.